Today, at the urging of the Human Rights Campaign (HRC), the New York attorney general has begun investigating whether Turing Pharmaceuticals, which recently imposed an unconscionable 5000 percent price hike on the life-saving drug Daraprim, may have violated antitrust laws by limiting its distribution. Chad Griffin, President of HRC, America’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organisation, released the following statement:
